Thanks to Angelina Jolie and other cultural forces, many American women are now aware of the BRCA test. But they're still unaware of the genetic counseling that should come with it.
A new study adds ammunition to researchers' argument that doctors should stop using software that's now used in 90 percent of mammograms.
An Austrian study finds that by going public about her double mastectomy, the actress increased knowledge about breast cancer.
Black women and white women in the United States lead very different lives—economically, socially, geographically. And those differences affect their health, but apparently not any of the official recommendations about their health.
Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable. Says one researcher: "What is scientific and sexy is driven by what can be monetized."
In New Jersey, people who believe they’ve qualified for Medicaid coverage under the health reform law might not actually be enrolled.
A new study shows that more women with breast cancer are choosing a mastectomy over a lumpectomy. Could money be playing a role in the decision?
New research finds a surprising link between high-status occupations among American women in the 1970s and later episodes of breast cancer.
Angelina Jolie is no less a woman without her natural breasts than the Boston victims are less than human without their legs.
Angelina Jolie's op-ed about her decision to undergo a double mastectomy will inspire women to consider preventive surgeries, but it neglects to mention the controversial politics behind the test that uncovered her risk for breast cancer.
Researchers found Nancy Reagan’s decision to have a breast removed influenced the choices of American women facing a similar medical issue.
Angelina Jolie's decision to undergo a double mastectomy was a tough one, but it was her decision to make. What would you have done in the same situation? And is there even a "same situation," when different doctors might offer different approximations of your chances of developing breast cancer?
Could the radiation from screening actually increase the odds of developing breast cancer among women with a specific gene?
Three years ago, a health task force sparked a heated debate when it recommended that women between 40 and 50 stop getting mammograms every year. Did timing, insurance, and emotion quash their findings?
A court case surrounding gene patents for high-risk forms of breast cancer puts two viewpoints of "products of nature" on the stand.
When it comes to new treatment guidelines for breast cancer, back pain and other maladies, it's the narrative presentation that matters.
Reaching the potential of personalized medicine is as much a matter of logistics as science.
Research suggests a possible specific target for drugs fighting the most common type of breast cancer.
